The study is the largest ever real-world analysis of the abortion pill. It found that the "rate of serious adverse events following mifepristone abortions is at least 22 times as high" as reported by the FDA on the drug label.

According to research conducted by the Ethics and Public Policy Center (EPPC), nearly 11 percent of women who took the pill experienced sepsis, infection, hemorrhaging, or other serious adverse events within 45 days of taking mifepristone to induce an abortion.

The EPPC based its research on data from all-payer insurance claims, which revealed that more than 94,000 complications were reported among the more than 865,000 prescribed mifepristone abortions between 2017 and 2023.

Center for Christian Virtue is calling on the FDA to revoke approval of mifepristone immediately while further research is conducted to protect the health and safety of women.

“Planned Parenthood has pushed the lie for years that the abortion pill is safe for women,” said Aaron Baer, President of CCV. “Considering that the Ohio Department of Health reports that in 2023, nearly half of the 22,000 abortions performed in Ohio in 2023 used Mifepristone, the FDA cannot delay in pulling this drug from pharmacy shelves while more research is conducted.”

TAKE ACTION NOW: TELL DC POLICYMAKERS THAT THE ABORTION PILL HARMS WOMEN

Use Center for Christian Virtue’s One-Click Action Center to call on your US Representative and US Senator, as well as Secretary of Health and Human Services Robert F. Kennedy, Jr., and FDA Commissioner Martin Makary, MD, to revoke the FDA approval for the abortion pill, also known as mifepristone, to protect the lives of women.

LEARN MORE

Read more about the study at StopHarmingWomen.org.